As both currently used diagnostic antibodies (e.g. RF and ACPA antibodies) are involved in the pathogenesis of RA [4], it is interesting to speculate which functionalities the newly identified antigenic targets may have, as this might open up new fields of research into the pathogenesis of RA. This evidence concerns the gene PRTN3 and rheumatoid arthritis.